7JK-12664-14981
4 vaccinations
2 coded responses
46 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 523 / IA
- Registered
- 2021-01-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-30
Registered in v-safe
-
2021-01-30
Dose 1 — Pfizer-BioNTech
- 2021-02-04
- 2021-02-05
- 2021-02-06
- 2021-02-13
- 2021-02-20
-
2021-02-25
Dose 2 — Pfizer-BioNTech
-
2021-02-27
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-28
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fever · Chills, Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-01
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fever · Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
- 2021-03-02
- 2021-03-03
- 2021-03-04
- 2021-03-11
- 2021-03-18
- 2021-03-25
- 2021-04-01
- 2021-04-08
- 2021-05-29
-
2021-08-26
Survey response — 6 months, dose 2MedDRA: Pregnancy — Feeling: GoodFree text: PregnancyMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-11-12
Dose 3 — Pfizer-BioNTech
- 2021-11-12
-
2021-11-13
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-11-14
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-11-15
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-11-16
- 2021-11-17
- 2021-11-18
- 2021-11-21
- 2021-11-28
- 2021-12-10
- 2021-12-19
- 2021-12-25
- 2022-02-11
- 2022-05-13
-
2022-10-10
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-10
-
2022-10-11
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Joint pains, Fatigue or tirednessAdult check-in
- 2022-10-12
-
2022-10-14
Survey response — days 1–6 daily, dose 4MedDRA: Hyperaesthesia, Paraesthesia — Feeling: GoodFree text: Pins/needles/sensitivity to touch on extremity of injection but on posterior upper armMedDRA releases: 2024-11 · check-in free text available
- 2022-10-15
- 2022-10-16
- 2022-10-19
- 2022-10-24
- 2022-10-31
- 2022-11-07
- 2022-11-14
- 2022-11-23
- 2023-01-09
- 2023-04-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-30 | Pfizer-BioNTech | |
| 2 | 2021-02-25 | Pfizer-BioNTech | |
| 3 | 2021-11-12 | Pfizer-BioNTech | No |
| 4 | 2022-10-10 | Pfizer-BioNTech | Flu |
Free text
Release 9 — 6 months, dose 2
Symptoms: Pregnancy
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Pins/needles/sensitivity to touch on extremity of injection but on posterior upper arm
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pregnancy | ✓ | · | ✓ |
| SRO | Hyperaesthesia | · | · | ✓ |
| SRO | Paraesthesia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release